1-3 of 3
Nicole Blackman
Close
Sort by
Journal Articles

Dosing of Rviii-Singlechain Based on Clinical Bleeding Phenotypes Results in Low Bleeding Rates and Low Consumption in Patients Treated with Prophylaxis Two or Three Times Weekly

Katie St Ledger, Nicole Blackman, Alex Veldman, MD, Ingrid Pabinger, for the Affinity Study Group
Journal: Blood
Blood (2016) 128 (22): 4969.
https://doi.org/10.1182/blood.V128.22.4969.4969
Published: 2016
Journal Articles

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Clinical Trials & Observations
Johnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, Oleksandra Stasyshyn, Marina V. Kosinova, Lynda Mae Lepatan, Aleksander Skotnicki, Lisa N. Boggio, Robert Klamroth, Johannes Oldenburg, Andrzej Hellmann, Elena Santagostino, Ross I. Baker, Kathelijn Fischer, Joan C. Gill, Stephanie P’Ng, Pratima Chowdary, Miguel A. Escobar, Claudia Djambas Khayat, Luminita Rusen, Debra Bensen-Kennedy, Nicole Blackman, Tharin Limsakun, Alex Veldman, Katie St. Ledger, Ingrid Pabinger, for the AFFINITY Investigators
Journal: Blood
Blood (2016) 128 (5): 630–637.
https://doi.org/10.1182/blood-2016-01-687434
Published: 2016
Includes: Supplemental data
Journal Articles

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Clinical Trials & Observations
Elena Santagostino, Uri Martinowitz, Toshko Lissitchkov, Brigitte Pan-Petesch, Hideji Hanabusa, Johannes Oldenburg, Lisa Boggio, Claude Negrier, Ingrid Pabinger, Mario von Depka Prondzinski, Carmen Altisent, Giancarlo Castaman, Koji Yamamoto, Maria-Teresa Álvarez-Roman, Christine Voigt, Nicole Blackman, Iris Jacobs
Journal: Blood
Blood (2016) 127 (14): 1761–1769.
https://doi.org/10.1182/blood-2015-09-669234
Published: 2016
Includes: Supplemental data